Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02828553 · ClinicalTrials.gov registry record
CHF Inpatient Ambulation Trial
A clinical trial of Heart Failure, sponsored by Lancaster General Hospital.
- Completed
- Registry status
- 352
- Enrollment target
- 1
- Study location
NCT02828553 is a study of Heart Failure that has completed, run by Lancaster General Hospital. The registered enrollment target is 352 participants, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02828553, a study of Heart Failure, has completed, sponsored by Lancaster General Hospital.
- COMPLETED
- Registry status
- 352 participants
- Enrollment target
- 1
- Study location
Study Summary
There is an overwhelming amount of deconditioning that occurs during the hospitalization to a patient admitted with a primary diagnosis of congestive heart failure. The goals of this study are to determine if monitored activity and aggressive mobility provides improved outcomes in hospitalized heart failure patients.
Conditions Studied
Interventions
- OTHER Aggressive planned ambulation with a mobility aide
Study Locations (1)
Pennsylvania
- Lancaster General Hospital - Lancaster
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 352 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02828553
The ClinicalTrials.gov registry entry for NCT02828553 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 352 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,048-participant average among 397 other Heart Failure trials with a reported enrollment target (83% lower). The listed sponsor is Lancaster General Hospital, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Aggressive planned ambulation with a mobility aide is the first listed.
NCT02828553 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT02828553 about?
NCT02828553 is a clinical study titled "CHF Inpatient Ambulation Trial". There is an overwhelming amount of deconditioning that occurs during the hospitalization to a patient admitted with a primary diagnosis of congestive heart failure. The goals of this study are to determine if monitored activity and aggressive mobility provides improved outcomes in hospitalized heart...
What is the current status of trial NCT02828553?
This trial is currently completed. The enrollment target is 352 participants. The study started on 2016-10. Estimated completion is 2018-12-31.
What conditions does trial NCT02828553 study?
This clinical trial studies the following conditions: Heart Failure.
What interventions are being tested in trial NCT02828553?
The interventions under investigation include: Aggressive planned ambulation with a mobility aide (OTHER).
Who is sponsoring clinical trial NCT02828553?
This trial is sponsored by Lancaster General Hospital, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02828553 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.